002382.SHE Blue Sail Medical Co Ltd
- Market cap
- CNY 5.58B
- P/E
- -
- P/B
- 0.73x
- ROE
- 2.8%
- Dividend yield
- 3.02%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is 002382.SHE undervalued?
Graham numberThe Graham number of Blue Sail Medical Co Ltd cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Blue Sail Medical Co Ltd fundamental analysis
No fundamental analysis for Blue Sail Medical Co Ltd yet.
Blue Sail Medical Co Ltd stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Blue Sail Medical Co Ltd
Blue Sail Medical Co.,Ltd. operates as a medical device company in China and internationally. It operates through Health Protection Division, Cardiovascular and Cerebrovascular Business Unit, and Emergency Medical Services segments. The company offers cardiovascular and cerebrovascular products comprising drug-eluting stents and balloons, and transcatheter aortic valve replacement systems; and health protection gloves consisting of disposable nitrile, PVC, latex, TPE/CPE, an…
Full company profileBlue Sail Medical Co Ltd financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Blue Sail Medical Co Ltd annual financial statements (CNY; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 1.29B | 1.58B | 2.65B | 3.48B | 7.87B | 8.11B | 4.90B | 4.93B | 6.25B | 5.74B | 7.38B |
| Gross Profit | 347M | 487M | 1.06B | 1.61B | 5.06B | 3.73B | 419M | 534M | 991M | 899M | 2.04B |
| Operating Income | 217M | 258M | 364M | 568M | 2.04B | 1.39B | -402M | -605M | -417M | -169M | 935M |
| EBITDA | 267M | 309M | 572M | 880M | 2.43B | 1.80B | 201M | 69.1M | 392M | 183M | 784M |
| Net Income | 181M | 201M | 347M | 490M | 1.76B | 1.16B | -372M | -568M | -446M | -759M | 210M |
| EPS | 0.37 | 0.41 | 0.47 | 0.51 | 1.73 | 1.10 | -0.37 | -0.56 | -0.44 | -0.75 | 0.21 |
| Balance Sheet | |||||||||||
| Total Assets | 1.59B | 1.84B | 12.7B | 13.3B | 17.0B | 16.9B | 15.9B | 15.6B | 16.8B | 16.8B | 14.9B |
| Total Liabilities | 287M | 409M | 4.90B | 4.80B | 7.22B | 6.38B | 5.32B | 6.08B | 7.00B | 7.30B | 5.44B |
| Shareholders' Equity | 1.30B | 1.43B | 7.80B | 8.43B | 9.82B | 10.5B | 10.6B | 9.55B | 8.19B | 7.17B | 7.46B |
| Cash & Short-term Investments | 289M | 239M | 1.89B | 2.25B | 4.82B | 3.49B | 2.53B | 1.59B | 2.27B | 1.70B | 920M |
| Total Debt | 59.4M | 61.3M | 3.71B | 3.68B | 5.56B | 3.73B | 3.21B | 2.37B | 3.15B | - | - |
| Cash Flow | |||||||||||
| Operating Cash Flow | 164M | 228M | 649M | 783M | 3.67B | 2.25B | 494M | -72.9M | 136M | 458M | - |
| Capital Expenditure | 99.7M | 256M | 441M | 357M | 1.20B | 2.58B | 897M | 774M | 774M | 553M | 487M |
| Free Cash Flow | 64.2M | -28.2M | 208M | 426M | 2.47B | -336M | -402M | -847M | -638M | -95.3M | 456M |
| Ratios | |||||||||||
| ROE | 13.9% | 14.1% | 4.4% | 5.8% | 17.9% | 11.0% | -3.5% | -6.0% | -5.4% | -10.6% | 2.8% |
| ROA | 11.4% | 10.9% | 2.7% | 3.7% | 10.3% | 6.8% | -2.3% | -3.6% | -2.7% | -4.5% | 1.4% |
| Net Profit Margin | 14.0% | 12.7% | 13.1% | 14.1% | 22.3% | 14.3% | -7.6% | -11.5% | -7.1% | -13.2% | 2.8% |
| Debt to Equity | 0.05x | 0.04x | 0.48x | 0.44x | 0.57x | 0.35x | 0.30x | 0.25x | 0.39x | - | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Blue Sail Medical Co Ltd dividends
- Dividend yield
- 3.02%
- Forward dividend
- -
- Payout ratio
- -
- Ex-dividend date
- May 31, 2023
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | CNY 168M | 0.17 | - |
| 2024 | CNY 177M | 0.18 | - |
| 2023 | CNY 514M | 0.51 | - |
| 2022 | CNY 61.0M | 0.06 | - |
| 2021 | CNY 403M | 0.38 | 34.8% |
| 2020 | CNY 96.4M | 0.09 | 5.5% |
| 2019 | CNY 38.6M | 0.04 | 7.9% |
| 2018 | CNY 156M | 0.21 | 45.1% |
| 2017 | CNY 100M | 0.21 | 50.0% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 20:10 on May 17, 2016.
Who owns Blue Sail Medical Co Ltd
- Insiders 34.45%
- Institutions 1.89%
- Public & others 63.66%
- Shares outstanding 1.01B
- Free float 698M
Blue Sail Medical Co Ltd company profile
- Company name
- Blue Sail Medical Co Ltd
- Ticker
- 002382.SHE
- ISIN
- CNE100000MZ7
- Exchange
- Shenzhen Stock Exchange
- Listed since
- Apr 2, 2010
- Sector
- Healthcare
- Industry
- Health Care Equipment & Supplies
- Employees
- 8,962
- Fiscal year end
- December
- Address
- No. 48, Yinuo Road, Zibo, China, 255400
- Phone
- 86 53 3787 1013
- Website
- bluesail.cn
About Blue Sail Medical Co Ltd
Blue Sail Medical Co.,Ltd. operates as a medical device company in China and internationally. It operates through Health Protection Division, Cardiovascular and Cerebrovascular Business Unit, and Emergency Medical Services segments. The company offers cardiovascular and cerebrovascular products comprising drug-eluting stents and balloons, and transcatheter aortic valve replacement systems; and health protection gloves consisting of disposable nitrile, PVC, latex, TPE/CPE, and polyurethane gloves for use in medical examinations, food processing, industrial labor protection, daily protection, and other applications. It also provides emergency rescue products, such as first-aid kits and disposable health protection supplies; antibody and mussel adhesive protein products; and wet wipes. In addition, the company offers cardio and neurovascular products for coronary intervention; minimally invasive surgery products, including powered endo and endoscopic staplers, open and anorectal staplers, energy sealing and dissecting instruments, access instruments, and other instruments; and disposable face masks. Further, it engages in the manufacture of rubber products, spunlace nonwoven fabric rolls, and interventional valve products for structural heart disease; sale of plastic products and sporting goods; asset and investment management; trading; research and development; business consulting; technology promotion; transfer of medical technology patent rights; textile and apparel; and electricity and heat production activities. The company sells its products under the Blue Sail brand. It serves hospitals; traders of first-aid kits and medical dressings; and distributors of automotive parts and accessories. The company was formerly known as Shandong Blue Sail Plastic & Rubber Co., Ltd. and changed its name to Blue Sail Medical Co.,Ltd. in July 2014. Blue Sail Medical Co.,Ltd. was founded in 2002 and is headquartered in Zibo, China.
Blue Sail Medical Co Ltd management
3- Mr. Shuqiao ZhongPresident, GM, Chief Capital Officer & Non-Independent Director · born 1985
- Mr. Yuntao CuiVP, Accounting Supervisor & CFO · born 1978
- Ms. Wang ZiyiSecretary to the Board · born 1993